Statistics
Publications
3
Citations
70
H-Index
3
Active since
2024
Affiliations
Bingtan Du is an author at Xinjiang Normal University specializing in prostate cancer, immunotherapy for genitourinary cancers, and t cell-mediated tumor control.
Publications per year
2024–2025
3
3
Intrinsic ADRB2 inhibition improves CAR-T cell therapy efficacy against prostate cancer
Iqra Ajmal, Muhammad Asad Farooq, Yixin Duan et al. · Molecular Therapy · 2024 · 30 citations · Full text
Medicine, Cancer Biology, Oncology +17
1–3 of 3